These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 1631786)
1. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism. Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786 [TBL] [Abstract][Full Text] [Related]
2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A; Ruusuvaara L Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043 [TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system. Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812 [TBL] [Abstract][Full Text] [Related]
4. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity]. Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860 [TBL] [Abstract][Full Text] [Related]
5. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167 [TBL] [Abstract][Full Text] [Related]
6. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Juhan-Vague I; Valadier J; Alessi MC; Aillaud MF; Ansaldi J; Philip-Joet C; Holvoet P; Serradimigni A; Collen D Thromb Haemost; 1987 Feb; 57(1):67-72. PubMed ID: 3109059 [TBL] [Abstract][Full Text] [Related]
7. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis]. Opatrný K; Vít L; Opatrná S; Sulková S; Bodláková B Cas Lek Cesk; 1994 May; 133(11):346-9. PubMed ID: 8004664 [TBL] [Abstract][Full Text] [Related]
8. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects. Stegnar M; Mavri A Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828 [TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion. Trotti R; Siragusa S; Rondanelli M; Chezzi L; Citterio A; Melzi d'Eril GV; Piovella F Haematologica; 1997; 82(2):178-81. PubMed ID: 9175322 [TBL] [Abstract][Full Text] [Related]
10. Levels of fibrinolytic activators and inhibitors in plasma after severe trauma. Sørensen JV Blood Coagul Fibrinolysis; 1994 Feb; 5(1):43-9. PubMed ID: 7514044 [TBL] [Abstract][Full Text] [Related]
11. Prospective double-arm study of fibrinolysis in surgical patients. Kosir MA; Schmittinger L; Barno-Winarski L; Duddella P; Pone M; Perales A; Lange P; Brish LK; McGee K; Beleski K; Pawlak J; Mammen E; Sajahan NP; Kozol RA J Surg Res; 1998 Jan; 74(1):96-101. PubMed ID: 9536981 [TBL] [Abstract][Full Text] [Related]
12. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium. Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554 [TBL] [Abstract][Full Text] [Related]
13. [Impaired fibrinolytic response to the venous occlusion test in patients with cryptogenic colitis]. Gris JC; Schved JF; Raffanel C; Dubois A; Ribard D; Balmes JL Gastroenterol Clin Biol; 1991; 15(12):933-8. PubMed ID: 1783249 [TBL] [Abstract][Full Text] [Related]
14. A dynamic test to investigate potential tissue plasminogen activator activity. Comparison of deamino-8-D-argininevasopressin with venous occlusion in normal subjects and patients. Sultan Y; Harris A; Strauch G; Venot A; De Lauture D J Lab Clin Med; 1988 Jun; 111(6):645-53. PubMed ID: 3131470 [TBL] [Abstract][Full Text] [Related]
15. [Disorders of the liberation of tissue-type plasminogen activator (t-PA) from the venous wall as a cause for recurrent thromboses]. Hach-Wunderle V; Scharrer I Vasa Suppl; 1993; 39():5-10. PubMed ID: 8322122 [TBL] [Abstract][Full Text] [Related]
16. Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release. Levi M; Lensing AW; Büller HR; Prandoni P; Dooijewaard G; Cuppini S; ten Cate JW Thromb Haemost; 1991 Oct; 66(4):426-9. PubMed ID: 1796391 [TBL] [Abstract][Full Text] [Related]
17. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion. Speidl WS; Zeiner A; Nikfardjam M; Geppert A; Jordanova N; Niessner A; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K J Am Coll Cardiol; 2005 Jan; 45(1):30-4. PubMed ID: 15629369 [TBL] [Abstract][Full Text] [Related]
18. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies. Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies. Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431 [TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery disease. Nikfardjam M; Graf S; Beckmann R; Hornykewycz S; Koller-Strametz J; Binder BR; Huber K Thromb Haemost; 1999 Sep; 82 Suppl 1():80-4. PubMed ID: 10695493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]